TTM Technologies Inc. Reports Strong Q1 Performance Amid Analyst Optimism

TTM Technologies Inc., a Nasdaq-listed company specializing in the manufacturing of printed circuit boards, has reported a robust first quarter for 2025. The company, which serves original equipment manufacturers and electronic manufacturing services companies, has seen a 14% increase in revenue and achieved record non-GAAP operating margins, despite facing challenges in the automotive sector.

Analyst Upgrades and Stock Performance

The positive financial results have been accompanied by favorable analyst assessments. Notably, Needham has raised its target price for TTM Technologies to $35, maintaining a “Buy” rating. This follows a broader trend of optimism, as B. Riley has also raised its stock target, reaffirming a “Strong Buy” recommendation.

Earnings Call Highlights

During the Q1 2025 earnings call, TTM Technologies highlighted its strong revenue growth and record operating margins. The company’s ability to navigate sector-specific challenges while maintaining robust financial performance has been a focal point for analysts and investors alike.

Market Reaction

The company’s stock has shown a rising relative price performance, although it remains shy of a key threshold. This technical improvement is reflected in an upgrade to its Relative Strength Rating, suggesting continued potential for growth.

Financial Overview

As of April 29, 2025, TTM Technologies’ stock closed at $20.02, with a 52-week high of $30.41 and a low of $15.77. The company’s market capitalization stands at approximately $2.04 billion, with a price-to-earnings ratio of 37.01.

Future Outlook

Analysts are optimistic about TTM Technologies’ future, with earnings per share (EPS) estimates for the quarter ending March 31, 2025, averaging $0.395, a significant increase from $0.100 in the same quarter of the previous year. The company is set to present its full Q1 2025 results on April 30, 2025.

Overall, TTM Technologies Inc. continues to demonstrate strong financial health and growth potential, supported by positive analyst coverage and solid operational performance.